UK Regulator Wants More Patient/Public Involvement In Decision-Making
Input Requested Into New Innovative Licensing Pathway
Executive Summary
In launching its latest consultation, the MHRA says it wants to see much more focus on the role of the ‘patient and public voice’ in shaping the way it makes regulatory decisions.
You may also be interested in...
UK MHRA Finalizes Strategy For Embedding Patient And Public Voice In Its Work
The UK MHRA has pushed back the timelines for delivering some of the objectives listed in its first five-year strategy on involving patients and public in regulatory decision-making.
England To Get ‘First Ever’ Patient Safety Commissioner Next Year
The UK government has revealed a number of changes it is making to the health care system in response to a report that found serious lapses regarding the safety of patients who were using certain treatments.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.